Hydantoin derivatives useful as Kv3 inhibitors
US11197859B2 · kind B2 · utility
1Cited by
13References
16Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 4, 2020 |
| Grant date | Dec 14, 2021 |
| Priority date | — |
| Expiry date | Aug 4, 2040 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D413/14
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The disclosure provides compounds of formula (I): said compounds being inhibitors of Kv3 channels and of use in the prophylaxis or treatment of related disorders.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.